Imigran FDT

Imigran FDT

sumatriptan

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Sumatriptan succinate
Indications/Uses
Acute relief of migraine w/ or w/o aura including migraine attacks associated w/ menstrual period.
Dosage/Direction for Use
Adult Single 50 or 100 mg dose. If no response to 1st dose, 2nd dose should not be taken for the same attack. If patient responded to the 1st dose, but symptoms recur, 2nd dose may be given in the next 24 hr provided not >300 mg is taken in any 24-hr period.
Administration
May be taken with or without food: For patients w/ difficulty swallowing, disperse tab in a small amount of water.
Contraindications
Hypersensitivity. Previous MI, ischaemic heart disease (IHD), Prinzmetal's angina/coronary vasospasm, peripheral vascular disease or patients who have symptoms or signs consistent w/ IHD. History of CVA or transient ischaemic attack (TIA). Uncontrolled HTN. Concomitant therapy w/ MAOIs, ergotamine or its derivatives. Severe hepatic impairment.
Special Precautions
Hypersensitivity to sulphonamides. Not to be used prophylactically. Not indicated for management of hemiplegic, basilar or ophthalmoplegic migraine. Not to be given in patients w/ CAD. Potentially serious neurological conditions eg, CVA, TIA. Controlled HTN; serotonin syndrome eg, altered mental status, autonomic instability & neuromuscular abnormalities; history of seizures or other risk factors lowering seizure threshold. May exacerbate headache due to medication overuse. Not recommended w/ co-administration of any triptan or 5-HT1 agonist. Concomitant use w/ SSRI & SNRIs. May affect ability to drive & use machines. Hepatic & renal impairment. Not to be given in postmenopausal women, males >40 yr. Pregnancy & lactation. Childn & adolescents <18 yr. Not recommended in elderly >65 yr.
Adverse Reactions
Dizziness, drowsiness, sensory disturbance eg, paraesthesia, hypoaesthesia; transient increased BP, flushing; dyspnoea; nausea & vomiting; heaviness sensation; pain, heat/cold sensation, pressure/tightness; weakness feeling, fatigue.
Drug Interactions
Prolonged vasospastic reactions w/ ergotamine. Serotonin syndrome w/ SSRIs, SNRIs. Concomitant use w/ MAOIs.
MIMS Class
Antimigraine Preparations
ATC Classification
N02CC01 - sumatriptan ; Belongs to the class of selective serotonin (5HT1) agonists preparations. Used to relieve migraine.
Presentation/Packing
Form
Imigran FDT tab 100 mg
Packing/Price
2's
Form
Imigran FDT tab 50 mg
Packing/Price
2's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in